Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 14122 | 28.69 |
09:33 ET | 1207 | 28.645 |
09:35 ET | 300 | 28.54 |
09:37 ET | 700 | 28.64 |
09:39 ET | 389 | 28.795 |
09:44 ET | 1128 | 28.7 |
09:46 ET | 1870 | 28.775 |
09:48 ET | 300 | 28.795 |
09:50 ET | 4361 | 28.91 |
09:51 ET | 6710 | 28.795 |
09:53 ET | 1573 | 28.885 |
09:55 ET | 100 | 28.88 |
09:57 ET | 1850 | 28.845 |
10:00 ET | 1500 | 28.78 |
10:02 ET | 8053 | 28.855 |
10:04 ET | 4971 | 28.77 |
10:06 ET | 300 | 28.755 |
10:08 ET | 4682 | 28.77 |
10:09 ET | 200 | 28.74 |
10:11 ET | 7570 | 28.8 |
10:13 ET | 8603 | 28.94 |
10:15 ET | 100 | 28.945 |
10:18 ET | 2447 | 28.99 |
10:20 ET | 1877 | 28.97 |
10:22 ET | 2700 | 28.93 |
10:24 ET | 2800 | 28.95 |
10:26 ET | 597 | 28.92 |
10:27 ET | 600 | 28.9 |
10:29 ET | 6448 | 28.84 |
10:31 ET | 1919 | 28.8199 |
10:33 ET | 1300 | 28.835 |
10:36 ET | 12501 | 28.8 |
10:38 ET | 620 | 28.72 |
10:40 ET | 100 | 28.7 |
10:42 ET | 700 | 28.69 |
10:44 ET | 58410 | 28.64 |
10:45 ET | 2600 | 28.59 |
10:47 ET | 1676 | 28.56 |
10:49 ET | 2948 | 28.555 |
10:51 ET | 651 | 28.59 |
10:54 ET | 1200 | 28.595 |
10:56 ET | 1121 | 28.595 |
11:00 ET | 200 | 28.56 |
11:02 ET | 407 | 28.56 |
11:03 ET | 2441 | 28.56 |
11:05 ET | 33998 | 28.5 |
11:07 ET | 600 | 28.48 |
11:09 ET | 6780 | 28.38 |
11:12 ET | 300 | 28.405 |
11:14 ET | 4960 | 28.32 |
11:16 ET | 1022 | 28.305 |
11:18 ET | 8969 | 28.21 |
11:20 ET | 4272 | 28.26 |
11:21 ET | 50999 | 28.191 |
11:23 ET | 2800 | 28.21 |
11:25 ET | 3448 | 28.1 |
11:27 ET | 3205 | 28.22 |
11:30 ET | 400 | 28.19 |
11:32 ET | 700 | 28.24 |
11:34 ET | 5068 | 28.28 |
11:36 ET | 200 | 28.29 |
11:38 ET | 4159 | 28.33 |
11:39 ET | 4998 | 28.46 |
11:41 ET | 878 | 28.47 |
11:43 ET | 1603 | 28.435 |
11:45 ET | 2042 | 28.48 |
11:48 ET | 100 | 28.465 |
11:50 ET | 1141 | 28.47 |
11:52 ET | 2139 | 28.49 |
11:54 ET | 1995 | 28.48 |
11:56 ET | 2004 | 28.525 |
11:57 ET | 836 | 28.505 |
11:59 ET | 1100 | 28.515 |
12:01 ET | 2568 | 28.64 |
12:03 ET | 34528 | 28.6 |
12:06 ET | 3628 | 28.53 |
12:08 ET | 10493 | 28.48 |
12:10 ET | 1900 | 28.46 |
12:12 ET | 100 | 28.47 |
12:14 ET | 2480 | 28.36 |
12:15 ET | 28766 | 28.45 |
12:17 ET | 809 | 28.46 |
12:19 ET | 1107 | 28.51 |
12:21 ET | 725 | 28.57 |
12:24 ET | 2994 | 28.57 |
12:26 ET | 200 | 28.56 |
12:28 ET | 13081 | 28.56 |
12:30 ET | 429 | 28.56 |
12:32 ET | 1830 | 28.55 |
12:33 ET | 1128 | 28.59 |
12:35 ET | 430 | 28.6089 |
12:37 ET | 2185 | 28.5357 |
12:39 ET | 1874 | 28.53 |
12:42 ET | 3425 | 28.53 |
12:44 ET | 4093 | 28.51 |
12:46 ET | 970 | 28.59 |
12:48 ET | 225 | 28.575 |
12:50 ET | 300 | 28.575 |
12:51 ET | 1631 | 28.56 |
12:53 ET | 2500 | 28.495 |
12:55 ET | 1326 | 28.51 |
12:57 ET | 300 | 28.51 |
01:00 ET | 3550 | 28.42 |
01:02 ET | 995 | 28.43 |
01:04 ET | 702 | 28.44 |
01:06 ET | 29536 | 28.39 |
01:08 ET | 3457 | 28.39 |
01:09 ET | 5626 | 28.345 |
01:11 ET | 1849 | 28.345 |
01:13 ET | 9163 | 28.34 |
01:15 ET | 300 | 28.355 |
01:18 ET | 800 | 28.35 |
01:20 ET | 1600 | 28.39 |
01:22 ET | 800 | 28.42 |
01:24 ET | 1286 | 28.44 |
01:26 ET | 520 | 28.44 |
01:27 ET | 3303 | 28.445 |
01:29 ET | 13067 | 28.375 |
01:31 ET | 1000 | 28.345 |
01:33 ET | 3225 | 28.4 |
01:36 ET | 800 | 28.4 |
01:38 ET | 7783 | 28.44 |
01:40 ET | 4866 | 28.43 |
01:42 ET | 2723 | 28.45 |
01:44 ET | 3171 | 28.45 |
01:45 ET | 3825 | 28.47 |
01:47 ET | 3555 | 28.49 |
01:49 ET | 1027 | 28.55 |
01:51 ET | 1700 | 28.59 |
01:54 ET | 2797 | 28.485 |
01:56 ET | 700 | 28.475 |
02:00 ET | 2838 | 28.5 |
02:02 ET | 3472 | 28.53 |
02:03 ET | 5283 | 28.54 |
02:05 ET | 24277 | 28.585 |
02:07 ET | 8863 | 28.55 |
02:09 ET | 900 | 28.62 |
02:12 ET | 1051 | 28.63 |
02:14 ET | 1400 | 28.59 |
02:16 ET | 12405 | 28.5 |
02:18 ET | 2041 | 28.5 |
02:20 ET | 400 | 28.53 |
02:21 ET | 1600 | 28.5425 |
02:23 ET | 1310 | 28.52 |
02:25 ET | 1280 | 28.575 |
02:27 ET | 600 | 28.575 |
02:30 ET | 700 | 28.5825 |
02:32 ET | 16943 | 28.52 |
02:34 ET | 3662 | 28.535 |
02:36 ET | 1500 | 28.525 |
02:38 ET | 5192 | 28.51 |
02:39 ET | 1900 | 28.51 |
02:41 ET | 2979 | 28.497 |
02:43 ET | 400 | 28.49 |
02:45 ET | 3141 | 28.515 |
02:48 ET | 4774 | 28.4999 |
02:50 ET | 43728 | 28.61 |
02:52 ET | 900 | 28.66 |
02:54 ET | 3400 | 28.58 |
02:56 ET | 16259 | 28.58 |
02:57 ET | 1947 | 28.56 |
02:59 ET | 1480 | 28.6 |
03:01 ET | 1549 | 28.5699 |
03:03 ET | 1862 | 28.55 |
03:06 ET | 3376 | 28.555 |
03:08 ET | 423 | 28.5699 |
03:10 ET | 2679 | 28.52 |
03:12 ET | 1989 | 28.58 |
03:14 ET | 1160 | 28.55 |
03:15 ET | 1400 | 28.55 |
03:17 ET | 1854 | 28.52 |
03:19 ET | 2900 | 28.53 |
03:21 ET | 31133 | 28.515 |
03:24 ET | 900 | 28.52 |
03:26 ET | 3664 | 28.525 |
03:28 ET | 3464 | 28.53 |
03:30 ET | 2500 | 28.49 |
03:32 ET | 4951 | 28.47 |
03:33 ET | 2631 | 28.45 |
03:35 ET | 4100 | 28.45 |
03:37 ET | 5790 | 28.48 |
03:39 ET | 3897 | 28.5 |
03:42 ET | 11790 | 28.6 |
03:44 ET | 4181 | 28.64 |
03:46 ET | 7420 | 28.695 |
03:48 ET | 8391 | 28.72 |
03:50 ET | 15209 | 28.69 |
03:51 ET | 12097 | 28.73 |
03:53 ET | 24130 | 28.84 |
03:55 ET | 41348 | 28.795 |
03:57 ET | 23295 | 28.835 |
04:00 ET | 378214 | 28.86 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.7B | 9.8x | --- |
Exelixis Inc | 10.4B | 23.1x | -21.77% |
Qiagen NV | 9.8B | 137.5x | +12.66% |
P3 Health Partners Inc | 134.0M | -0.6x | --- |
Ionis Pharmaceuticals Inc | 6.2B | -16.0x | --- |
Novavax Inc | 1.4B | -3.2x | --- |
Alkermes plc is Ireland-based biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.7B |
---|---|
Revenue (TTM) | $1.5B |
Shares Outstanding | 161.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.45 |
EPS | $2.95 |
Book Value | $7.20 |
P/E Ratio | 9.8x |
Price/Sales (TTM) | 3.1 |
Price/Cash Flow (TTM) | 8.6x |
Operating Margin | 29.00% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.